Methods for enhancement of protective immune responses
US5876735A · kind A · utility
40Cited by
2References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 23, 1996 |
| Grant date | Mar 2, 1999 |
| Priority date | — |
| Expiry date | Feb 23, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for eliciting or enhancing immune responses to antigens, including tumor antigens, are provided. The methods employ polypeptides or nucleic acid compositions that contain at least a biologically active portion of a Leishmania braziliensis or Leishmania major homologue of the eukaryotic initiation factor 4A, or a variant thereof. Such polypeptides and compositions are useful for enhancing or eliciting a patient's cellular and/or humoral immune response, for instance within methods for treating tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.